Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma

Hepatology

Volumn 51, Issue 5, 2010, Pages 1624-1634

  Fu, Li ^a,b   Dong, Sui Sui ^b   Xie, Yi Wu ^b   Tai, Lai Shan ^b   Chen, Leilei ^b   Kong, Kar Lok ^b   Man, Kwan ^b   Xie, Dan ^a   Li, Yan ^a   Cheng, Yingduan ^c   Tao, Qian ^c   Guan, Xin Yuan ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CYTOCHROME C; DNA; GENOMIC DNA; RNA; SMALL INTERFERING RNA; TYROSINE AMINOTRANSFERASE;

ALLELE; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CHROMOSOME 16Q; CHROMOSOME DELETION; ENZYME REGULATION; FLUORESCENCE MICROSCOPE; GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYBRIDIZATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SOUTHERN BLOTTING; TISSUE MICROARRAY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 9; CHROMOSOMES, HUMAN, PAIR 16; CPG ISLANDS; CYTOCHROMES C; DNA METHYLATION; DOWN-REGULATION; ENZYME ACTIVATION; GENE DELETION; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; RNA, SMALL INTERFERING; TYROSINE TRANSAMINASE;

EID: 77951470463     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23540     Document Type: Article

References (24)

1. Harris CC. Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cells 1990;2:146-148. (Pubitemid 20344381)
2. Piao Z, Park C, Kim JJ, Kim H. Deletion mapping of chromosome 16q in hepatocellular carcinoma. Br J Cancer 1999;80:850-854. (Pubitemid 29209850)
3. Guan XY, Fang Y, Sham JST, Kwong DLW, Zhang Y, Liang Q, et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 2000;29:110-116.
4. Slagle BL, Zhou YZ, Birchmeier W, Scorsone KA. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. HEPATOLOGY 1993;18:757-762.
5. Shiman R, Gray DW. Formation and fate of tyrosine: intracellular partitioning of newly synthesized tyrosine in mammalian liver. J Biol Chem 1998;273:34760-34769. (Pubitemid 29028167)
6. Huhn R, Stoermer H, Klingele B, Bausch E, Fois A, Farnetani M, et al. Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia type II. Hum Genet 1998;102:305-313. (Pubitemid 28185219)
7. Paraskevopoulos JA. Management options for primary hepatocellular carcinoma, an overview. Acta Oncol 1994;33:895-900.
8. Paradis K. Tyrosinemia: the Quebec experience. Clin Invest Med 1996;19:311-316.
9. Fu L, Qin YR, Xie D, Hu L, Kwong DL, Srivastava G, et al. Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma. Cancer Res 2007;67:10720-10726. (Pubitemid 350145898)
10. Guan XY, Sham JST, Tang TCM, Fang Y, Huo KK, Yang JM. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res 2001;61:3806-3809. (Pubitemid 32694997)
11. Xie D, Sham JS, Zeng WF, Lin HL, Che LH, Wu HX, et al. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer 2003;107:896-902. (Pubitemid 37429830)
12. Okabe H, Ikai I, Matsuo K, Satoh S,Momoi H, Kamikawa T, et al. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. HEPATOLOGY 2000;31:1073-1079. (Pubitemid 30233231)
13. Nidoridawa Y, Yamamoto S, Ishikawa S, Kaminura N, Igarashi H, Sugimura H, et al. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene 2006;25:5581-5590. (Pubitemid 44344109)
14. Poylance R, Gorman P, Papior T, Wan YL, Ives M, Watson JE, et al. A comprehensive study of chromosome 16q in invasive ductal and lobular carcinoma using array CGH. Oncogene 2006;25:6544-6553. (Pubitemid 44607087)
15. Stanton SE, Shin SW, Johnson BE, Meyerson M. Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas. Genes Chromosomes Cancer 2000;27:323-331. (Pubitemid 30067463)
16. Suzuki S, Egami K, Sasajima K, Ghazizadeh M, Shimizu H, Watanabe H, et al. Comparative study between DNA copy number aberrations determined by quantitative microsatellite analysis and clinical outcome in patients with stomach cancer. Clin Cancer Res 2004;10:3013-3019. (Pubitemid 38619677)
17. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-646. (Pubitemid 16008560)
18. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization ofthe familial adenomatous polyposis coli gene. Cell 1991;66:589-600. (Pubitemid 121001394)
19. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumour types. Science 1994;264:436-440. (Pubitemid 24986726)
20. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP. Allele-specific hypermethylation of the retinoblastoma tumor suppressor gene. Am J Hum Genet 1991;48:880-888. (Pubitemid 21891632)
21. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-692.
22. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A 1995;92:7416-7419.
23. Kanai Y, Ushijima S, Tsuda H, Sakamoto M, Sugimura T, Hirohashi S. Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis. Jpn J Cancer Res 1996;87:1210-1217. (Pubitemid 27042363)
24. Rodriguez J, Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev 1999;13:3179-3184. (Pubitemid 30030439)